FCGR2C and breast cancer: Recently, we showed that extracellular CD32 (CD28/CD3ζ)-reactive T cells recognize ALs and trigger HLA-unrestricted cytotoxicity in a subset of BC cells, including triple-negative breast cancer (TNBC) cells [41].